illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. hospital & health care
  6. ›
  7. CellaVision
Company logo

CellaVision | Sustainability Performance

https://www.cellavision.com
Linkedin

CellaVision specializes in digital imaging and analysis solutions for blood diagnostics. The company provides products that aim to enhance laboratory efficiencies and accuracy.

1994

Sweden

201 - 500 employees

Medical Device

$25M - 100M in revenue

$10M - 25M in profitability

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#8177
Overall
#366
in Sweden
#121
in Medical Device

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Beyond Top 100

Overview
Governance
TargetsESG scores and Exclusions
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies


Company logo
Moberg Pharma

Sweden, Hospital & Health Care, Pharmaceuticals


Company logo
Recipharm

Sweden, Hospital & Health Care, Pharmaceuticals


Company logo
RaySafe

Sweden, Hospital & Health Care, Medical Device

Market cap

41.7B $, 2026▼7.1% YoY

Revenue

77.2M $, 2025▲4.6% YoY

R&D intensity

12.8% 2025

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
Powered by illuminem

Market cap

41.7B $, 2026▼7.1% YoY

Revenue

77.2M $, FY2025▲4.6% YoY

EBITDA

20.6M $, FY2025▼9.1% YoY

Operating margin

27% Industry: -136▲7.7% YoY

Revenue & EBITDA

$77.2MFY2025 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Margin trends


Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

11.6M 2025▼5.6% YoY

Capex

8.8M 2025▲10.5% YoY

Debt/equity ratio

0.0 Industry: 1▼NaN% YoY

R&D intensity

12.8%FY2025

R&D as % of revenue

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Return on invested capital

17.0%FY2026

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals


Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

0.1

▲ 3.6%

2023

0.1

▼ 2.5%

2024

0.1

▲ 0.6%

2025

0.9

2028

Powered by illuminem

Environmental policy coverage

Carbon reduction policy

Not available

Human rights policy

Available

Recycling policy

Not available

Workplace health & safety policy

Available

29%
Independent Directors

5 out of 17 incl. management

Powered by illuminem

Overall score

50

Environment

52

Social

55

Governance

42

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Not available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

Sustainability employees


Total sustainability employees

2-3



    Available in
    Scale package

    Access
  • Email

  • Email